Daclizumab Subcutaneous and Oxycodone and Aspirin
Determining the interaction of Daclizumab Subcutaneous and Oxycodone and Aspirin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: aspirin / oxycodone
Brand name: Percodan, Percodan-Demi, Roxiprin, Endodan
Synonyms: Aspirin and oxycodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Oxycodone and Ibuprofen
- Daclizumab Subcutaneous-Oxycodone and naloxone
- Daclizumab Subcutaneous-Oxycodone and naltrexone
- Daclizumab Subcutaneous-Oxycodone Capsules
- Daclizumab Subcutaneous-Oxycodone Capsules and Tablets
- Daclizumab Subcutaneous-Oxycodone Concentrate
- Oxycodone and Aspirin-Dacogen
- Oxycodone and Aspirin-Dacomitinib
- Oxycodone and Aspirin-Dactinomycin
- Oxycodone and Aspirin-Dactinomycin Injection
- Oxycodone and Aspirin-Dactinomycin Intravenous
- Oxycodone and Aspirin-Daklinza